These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15760052)

  • 1. Agglomeration of Ibuprofen with talc by novel crystallo-co-agglomeration technique.
    Pawar A; Paradkar A; Kadam S; Mahadik K
    AAPS PharmSciTech; 2004 Sep; 5(4):e55. PubMed ID: 15760052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallo-co-agglomeration: a novel technique to obtain ibuprofen-paracetamol agglomerates.
    Pawar AP; Paradkar AR; Kadam SS; Mahadik KR
    AAPS PharmSciTech; 2004 Jun; 5(3):e44. PubMed ID: 15760077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of deformable talc agglomerates prepared by crystallo-co-agglomeration technique for generating heterogeneous matrix.
    Jadhav N; Pawar A; Paradkar A
    AAPS PharmSciTech; 2007 Jul; 8(3):E59. PubMed ID: 17915809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of High-Strength Extended-Release Multiparticulate System by Crystallo-co-agglomeration Technique with Integration of Central Composite Design.
    Gaikwad VL; Jadhav NR; Pawar AP; Mahadik KR
    AAPS PharmSciTech; 2019 May; 20(5):192. PubMed ID: 31115715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique.
    Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A
    Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of excipients and processing conditions on the development of agglomerates of racecadotril by crystallo-co-agglomeration.
    Garala K; Patel J; Patel A; Raval M; Dharamsi A
    Int J Pharm Investig; 2012 Oct; 2(4):189-200. PubMed ID: 23580935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of agglomerated crystals by crystallo-co-agglomeration: an integrated approach of principal component analysis and Box-Behnken experimental design.
    Garala KC; Patel JM; Dhingani AP; Dharamsi AT
    Int J Pharm; 2013 Aug; 452(1-2):135-56. PubMed ID: 23684660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization.
    Maghsoodi M; Tajalli Bakhsh AS
    Pharm Dev Technol; 2011 Jun; 16(3):243-9. PubMed ID: 20175665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of polymers/excipients on development of agglomerated crystals of secnidazole by crystallo-co-agglomeration technique to improve processability.
    Raval MK; Sorathiya KR; Chauhan NP; Patel JM; Parikh RK; Sheth NR
    Drug Dev Ind Pharm; 2013 Mar; 39(3):437-46. PubMed ID: 22380546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of drug content and agglomerate size on tabletability and drug release characteristics of bromhexine hydrochloridetalc agglomerates prepared by crystallo-co-agglomeration.
    Jadhav N; Pawar A; Paradkar A
    Acta Pharm; 2010 Mar; 60(1):25-38. PubMed ID: 20228039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spherical crystallization of drugs.
    Kovačič B; Vrečer F; Planinšek O
    Acta Pharm; 2012 Mar; 62(1):1-14. PubMed ID: 22472445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique.
    Maghsoodi M
    Pharm Dev Technol; 2011 Oct; 16(5):474-82. PubMed ID: 20557281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting.
    Pandey S; Patil AT
    Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
    Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of microparticles of naproxen with Eudragit RS and talc by spherical crystallization technique.
    Maghsoodi M; Esfahani M
    Pharm Dev Technol; 2009; 14(4):442-50. PubMed ID: 19235551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spherical crystal agglomeration of ibuprofen by the solvent-change technique in presence of methacrylic polymers.
    Kachrimanis K; Nikolakakis I; Malamataris S
    J Pharm Sci; 2000 Feb; 89(2):250-9. PubMed ID: 10688754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spherical crystallization of celecoxib.
    Paradkar AR; Pawar AP; Chordiya JK; Patil VB; Ketkar AR
    Drug Dev Ind Pharm; 2002 Nov; 28(10):1213-20. PubMed ID: 12476867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melt sonocrystallization of ibuprofen: effect on crystal properties.
    Manish M; Harshal J; Anant P
    Eur J Pharm Sci; 2005 May; 25(1):41-8. PubMed ID: 15854799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.